Is it safe to take a single dose of fluconazole (Diflucan) while on a CYP‑3A4‑metabolized statin such as simvastatin, lovastatin, atorvastatin, or high‑dose rosuvastatin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Single-Dose Fluconazole with Statin Therapy

A single dose of fluconazole (Diflucan) can generally be taken while on statin therapy, but the safety profile varies significantly depending on which specific statin you are taking.

Risk Stratification by Statin Type

Lowest Risk Statins (Preferred)

  • Rosuvastatin, pravastatin, fluvastatin, and pitavastatin are the safest options when taking fluconazole 1
  • These statins are not metabolized by CYP3A4, the enzyme that fluconazole inhibits 2, 3
  • Rosuvastatin exposure increases by only 14% with fluconazole—a clinically insignificant change 3
  • No dose adjustment is necessary for these statins when taking a single dose of fluconazole 1

Moderate Risk Statins (Use with Caution)

  • Atorvastatin undergoes only minor CYP3A4 metabolism compared to simvastatin and lovastatin 2
  • While fluconazole can increase atorvastatin levels, the FDA label does not require dose adjustment for atorvastatin 1
  • A single dose poses minimal risk, but patients should be monitored for muscle symptoms 1

Highest Risk Statins (Greatest Concern)

  • Simvastatin and lovastatin are extensively metabolized by CYP3A4 2
  • Fluconazole is a moderate CYP3A4 inhibitor that can significantly increase statin blood levels 1
  • Multiple case reports document rhabdomyolysis from the simvastatin-fluconazole combination 4, 5
  • The risk increases with higher statin doses (≥40 mg daily) 6

Mechanism of Interaction

Fluconazole inhibits CYP3A4, CYP2C9, and CYP2C19 enzymes, with particularly strong inhibition of CYP2C19 1. This enzyme inhibition persists for 4-5 days after discontinuing fluconazole due to its long half-life 1. For CYP3A4-metabolized statins (simvastatin, lovastatin, atorvastatin), this results in:

  • Decreased statin metabolism and clearance 7, 8
  • Increased plasma concentrations of active statin forms 6, 9
  • Elevated risk of myopathy and rhabdomyolysis 1, 4, 5

Clinical Recommendations

For patients on simvastatin or lovastatin:

  • Consider temporarily holding the statin for the duration of fluconazole therapy plus 4-5 days 1
  • If continuation is necessary, reduce the statin dose and monitor closely for muscle symptoms 1
  • Watch for muscle pain, weakness, dark urine, or unexplained fatigue 4, 5

For patients on atorvastatin:

  • Continue the statin at the current dose for a single fluconazole dose 1
  • Advise the patient to report any muscle symptoms immediately 1

For patients on rosuvastatin, pravastatin, fluvastatin, or pitavastatin:

  • No special precautions needed beyond routine monitoring 1, 3
  • These combinations are considered safe 3

Important Caveats

  • The risk is dose-dependent for both medications—higher statin doses (≥40 mg) and higher fluconazole doses (≥400 mg) carry greater risk 1, 6
  • A single 150 mg fluconazole dose (typical for vaginal candidiasis) poses less risk than multi-day courses 1
  • Patients with renal impairment, advanced age, or multiple medications face higher baseline risk 4, 5
  • The interaction risk is greatest during the first week of combined therapy when fluconazole levels are highest 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.